BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  Spring Bank Pharmaceuticals, Inc. And Arbutus Biopharma Announce Preclinical Collaboration In Study Of Chronic Hepatitis B

  December 19, 2016

   · 

  4 min read
• Biotech Bay

  Amunix, Inc. Release: IND Submission To Initiate Clinical Trials Of NB 1001 (XTEN-GLP1) For Treatment Of Short Bowel Syndrome Announced By Naia Rare Diseases

  December 19, 2016

   · 

  2 min read
• BioCapital

  Neovasc Regains NASDAQ Compliance

  December 19, 2016

   · 

  1 min read
• Simavita Receives $1.65 Million Cash Payment Under R&D Tax Incentive Scheme

  December 19, 2016

   · 

  1 min read
• Business

  Portola Enters Into $50 Million Loan Agreement With Bristol-Myers Squibb And Pfizer For Continued Development Of Andexxa (Andexanet Alfa)

  December 19, 2016

   · 

  4 min read
• Neovasc Regains Compliance With NASDAQ Listing Requirements

  December 19, 2016

   · 

  1 min read
• FDA

  Anika Therapeutics Wins CE Mark Approval For ORTHOVISC-T To Relieve Pain And Restore Function Of Tendons Damaged By Chronic Injury

  December 19, 2016

   · 

  5 min read
• Policy

  AbbVie Submits New Drug Application To U.S. FDA For Its Investigational Regimen Of Glecaprevir/Pibrentasvir (G/P) For The Treatment Of All Major Genotypes Of Chronic Hepatitis C

  December 19, 2016

   · 

  6 min read
• BioForest

  Cancer Targeted Technology Commences Second Phase Of A $2.3M Contract To Develop An Innovative PSMA-Targeted Radionuclide Therapy For Prostate Cancer

  December 19, 2016

   · 

  2 min read
• Drug Development

  RedHill Biopharma Announces First Patient Dosed In Phase Ib/II Study With YELIV For Multiple Myeloma

  December 19, 2016

   · 

  7 min read